Impact of the EU Clinical Trials Regulation (CTR) No 536/2014

In this audio recording, our panel of industry experts walk you through a PCI Clinical Services watercooler chat discussing all the changes, benefits and potential disadvantages that the new EU Clinical Trial Regulation No 536/2014 will bring when it is finally made effective, sometime in the summer of 2022

The team will also compare and contrast how the CTR will differ from the current EU Clinical Trials Directive 2001/20/EC which has been the principal legal directive in place since 2004 governing how clinical trials are conducted in the EU.

Impact of the EU Clinical Trials Regulation (CTR) No 536/2014

Our dedicated team of specialists will be happy to discuss any of your Clinical Trials Regulation questions or concerns. Contact us on +1 779-208-1819 (US) or +44 1495 711 222 (UK/EU) or email talkfuture@pci.com

When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?

Your bridge between life-changing therapies and patients